The Vaso Shield is a permanent and transparent hydrogel product protected by multiple patents and patent applications, as well as a proprietary manufacturing process, according to the release. It is used commonly during anterior spinal implant procedures and is placed between the spinal implant and the vessels to protect them from subsequent anterior revision surgeries.
The new clearance is for multiple thicknesses ranging from 0.4 mm-1.0 mm.
Read the MiMedx release about the HydroFix Vaso Shield.
MiMedx Receives FDA Clearance for HydroFix Vaso ShieldWritten by Staff | June 07, 2010
MiMedx Group, an integrated developer, manufacturer and marketer of biomaterial-based products, has received notification 510(k) clearance by the U.S. Food and Drug Administration for additional thicknesses and sizes of its HydroFix Vaso Shield, according to a MiMedx news release.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.